Humanized medium (h7H) allows long-term primary follicular thyroid cultures from human normal thyroid, benign neoplasm, and cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 6, 2013, Pages 2431-2441

  Bravo, Susana B ^a   Garcia Rendueles, Maria E R ^a,d   Garcia Rendueles, Angela R ^a   Rodrigues, Joana S ^a   Perez Romero, Sihara ^a   Garcia Lavandeira, Montserrat ^a   Suarez Fariña, Maria ^a   Barreiro, Francisco ^b   Czarnocka, Barbara ^c   Senra, Ana ^a   Lareu, Maria V ^b   Rodriguez Garcia, Javier ^b   Cameselle Teijeiro, Jose ^b   Alvarez, Clara V ^a  

^a University of Santiago de Compostela ^*  (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIOXIDANT; CYTOKERATIN; IODINE; LIOTHYRONINE; PENDRIN; SODIUM IODIDE SYMPORTER; THYROGLOBULIN; THYROID PEROXIDASE; TRANSFERRIN;

ANIMAL CELL; ARTICLE; BLOOD LEVEL; CELL CULTURE; CELL PROLIFERATION; CULTURE MEDIUM; DISEASE CLASSIFICATION; FEMALE; GOITER; GRAVES DISEASE; HOMEOSTASIS; HUMAN; HUMAN CELL; MALE; METABOLITE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; THYROID ADENOMA; THYROID FOLLICLE CELL; THYROID FOLLICULAR CARCINOMA; THYROID HYPERPLASIA;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA; HUMANS; PHENOTYPE; RATS; THYROGLOBULIN; THYROID GLAND; THYROID NEOPLASMS; TRIIODOTHYRONINE;

RODENTIA;

EID: 84878486148     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3812     Document Type: Article

References (27)

1. Rastogi MV, LaFranchi SH. Congenital hypothyroidism. Orphanet J Rare Dis. 2010;5:17.
2. Corbetta C, Weber G, Cortinovis F, et al. A 7-year experience with low blood TSH cutoff levels for neonatal screening reveals an unsuspected frequency of congenital hypothyroidism (CH). Clin Endocrinol (Oxf). 2009;71(5):739-745.
3. McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42(2):252-265.
4. McLeod DS, Cooper DS. Erratum to: The incidence and prevalence of thyroid autoimmunity. Endocrine. 2013;43:244.
5. Eheman C, Henley SJ, Ballard-Barbash R, et al. Annual report to the nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer. 2012;118(9):2338-2366.
6. Goretzki PE, Frilling A, Simon D, Roeher HD. Growth regulation of normal thyroids and thyroid tumors in man. Recent Results Cancer Res. 1990;118:48-63.
7. Lemoine NR, Mayall ES, Jones T, et al. Characterisation of human thyroid epithelial cells immortalised in vitro by simian virus 40DNA transfection. Br J Cancer. 1989;60(6):897-903. (Pubitemid 20024183)
8. Schweppe RE, Klopper JP, Korch C, et al. Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab. 2008;93(11):4331-4341. (Pubitemid 352789529)
9. Bravo SB, Pampin S, Cameselle-Teijeiro J, et al. TGF-β-induced apoptosis in human thyrocytes is mediated by p27kip1 reduction and is overridden in neoplastic thyrocytes by NF-κB activation. Oncogene. 2003;22(49):7819-7830. (Pubitemid 37485541)
10. Bravo SB, Garcia-Rendueles ME, Seoane R, et al. Plitidepsin has a cytostatic effect in human undifferentiated (anaplastic) thyroid carcinoma. Clin Cancer Res. 2005;11(21):7664-7673. (Pubitemid 41611608)
11. Palos F, Garcia-Rendueles ME, Araujo-Vilar D, et al. Pendred syndrome in two galician families: insights into clinical phenotypes through cellular, genetic, and molecular studies. J Clin Endocrinol Metab. 2008;93(1):267-277.
12. Lado-Abeal J, Celestino R, Bravo SB, et al. Identification of a paired box gene 8-peroxisome proliferator-activated receptor γ (PAX8-PPARγ) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH receptor. Endocr Relat Cancer. 2010;17(3):599-610.
13. Bravo SB, Garcia-Rendueles ME, Perez-Romero S, et al. Expression of exogenous proteins and short hairpin RNAs in human primary thyrocytes. Anal Biochem. 2010;400:219-228.
14. Ambesi-Impiombato FS, Parks LA, Coon HG. Culture of hormone-dependent functional epithelial cells from rat thyroids. Proc Natl Acad Sci USA. 1980;77(6):3455-3459. (Pubitemid 10012253)
15. Szkudlinski MW, Teh NG, Grossmann M, Tropea JE, Weintraub BD. Engineering human glycoprotein hormone superactive analogues. Nat Biotechnol. 1996;14(10):1257-1263. (Pubitemid 26332786)
16. Roth J, Grunfeld C. Endocrine systems: mechanisms of disease, target cells and receptors. In: Williams RH, ed. Textbook of Endocrinology, 6th ed. Philadelphia: Saunders; 1981:15-72.
17. Rudland PS, Seifert W, Gospodarowicz D. Growth control in cultured mouse fibroblasts: induction of the pleiotypic and mitogenic responses by a purified growth factor. Proc Natl Acad Sci USA. 1974;71(7):2600-2604.
18. Hellal-Levy C, Couette B, Fagart J, Souque A, Gomez-Sanchez C, Rafestin-Oblin M. Specific hydroxylations determine selective corticosteroid recognition by human glucocorticoid and mineralocorticoid receptors. FEBS Lett. 1999;464(1-2):9-13. (Pubitemid 30009740)
19. Blanco M, Bravo S, Garcia-Caballero T, et al. Localization of growth hormone receptors in rat and human thyroid cells. Cell Tissue Res. 2001;306(3):423-428. (Pubitemid 33139901)
20. Ying QL, Wray J, Nichols J, et al. The ground state of embryonic stem cell self-renewal. Nature. 2008;453(7194):519-523. (Pubitemid 351733324)
21. Eastman CJ, Zimmermann MB. The iodine deficiency disorders. http://www.thyroidmanager.org/chapter/the-iodine-deficiencydisorders/. Thyroid Disease Manager. (http://www.thyroidmanager.org). 2009.
22. American Type Culture Collection Standards Development Organization Workgroup ASN-0002. Cell line misidentification: the beginning of the end. Nat Rev Cancer. 2010;10(6):441-448.
23. Begley CG, Ellis LM. Drug development: raise standards for preclinical cancer research. Nature. 2012;483(7391):531-533.
24. Kusakabe T, Kawaguchi A, Hoshi N, Kawaguchi R, Hoshi S, Kimura S. Thyroid-specific enhancer-binding protein/NKX2.1 is required for the maintenance of ordered architecture and function of the differentiated thyroid. Mol Endocrinol. 2006;20(8):1796-1809. (Pubitemid 44148085)
25. Hoshi N, Kusakabe T, Taylor BJ, Kimura S. Side population cells in the mouse thyroid exhibit stem/progenitor cell-like characteristics. Endocrinology. 2007;148(9):4251-4258. (Pubitemid 47295711)
26. Toda S, Aoki S, Uchihashi K, et al. Culture models for studying thyroid biology and disorders. ISRN Endocrinol. 2011;2011:275782.
27. van Staveren WCG, Weiss Solis D, Delys L, et al. Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype. Cancer Res. 2007;67(17):8113-8120. (Pubitemid 47395146)